No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Inhibrx Biosciences Files to Sell 2.45M Shares of Common Stock for Holders
Inhibrx Biosciences(INBX.US) Director Buys US$997.02K in Common Stock
Express News | Inhibrx Biosciences 13G Filing Shows Viking Global Investors LP Reported A 12.3% Stake In The Co As Of May 29, 2024
Express News | Viking Global Investors LP Reports 12.3% Passive Stake in Inhibrx Biosciences, Inc. as of May 29, 2024- SEC Filing
Top 4 Health Care Stocks That Are Preparing To Pump This Month
Inhibrx Biosciences Insider Bought Shares Worth $4,927,580, According to a Recent SEC Filing